The transcriptomic response of rat hepatic stellate cells to endotoxin: Implications for hepatic inflammation and immune regulation

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Harvey, Stephen A K ^a   Dangi, Anil ^b,c   Tandon, Ashish ^b   Gandhi, Chandrashekhar R ^b,c,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BACTERIUM LIPOPOLYSACCHARIDE; BETA CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 17F; MITOGEN ACTIVATED PROTEIN KINASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HEPATITIS; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INTERFERON GENE; IRAK GENE; MALE; MAPK GENE; NF KAPPA B GENE; NONHUMAN; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SOCS GENE; STAT GENE; STELLATE CELL; TRANSCRIPTOMICS;

ANIMALS; ANTIGEN PRESENTATION; CHEMOKINES; DOWN-REGULATION; HEPATIC STELLATE CELLS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RESPONSE ELEMENTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

EID: 84891916013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082159     Document Type: Article

References (85)

1. Crispe IN (2009) The liver as a lymphoid organ. Annu Rev Immunol 27:147-163. doi:10.1146/annurev. immunol.021908.132629. PubMed: 19302037.
2. Thomson AW, Knolle PA (2010) Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 10:753-766. doi: 10.1038/nri2858. PubMed: 20972472.
3. Mehal WZ, Azzaroli F, Crispe IN (2001) Immunology of the healthy liver: old questions and new insights. Gastroenterology 120:250-260. doi:10.1053/gast.2001.20947. PubMed: 11208734. (Pubitemid 32061889)
4. Belz GT, Altman JD, Doherty PC (1998) Characteristics of virusspecific CD8 (+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci U S A 95:13812-13817. doi:10.1073/pnas.95.23.13812. PubMed: 9811883. (Pubitemid 28523055)
5. Crispe IN (2003) Hepatic T cells and liver tolerance. Nat Rev Immunol 3:51-62. doi:10.1038/nri981. PubMed: 12511875. (Pubitemid 37328699)
6. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR et al. (1969) Induction of immunological tolerance by porcine liver allografts. Nature 223:472-476. doi:10.1038/223472a0. PubMed: 4894426.
7. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ et al. (1994) Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 19:916-924. doi:10.1002/hep. 1840190418. PubMed: 8138266. (Pubitemid 24109354)
8. Gugenheim J, Samuel D, Reynes M, Bismuth H (1990) Liver transplantation across ABO blood group barriers. Lancet 336:519-523. doi:10.1016/0140-6736 (90) 92082-S. PubMed: 1975036. (Pubitemid 20278096)
9. Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B et al. (1997) Weaning of immunosuppression in liver transplant recipients. Transplantation 63:243-249. doi: 10.1097/00007890-199701270-00012. PubMed: 9020325. (Pubitemid 27121206)
10. Takatsuki M, Uemoto S, Inomata Y, Egawa H, Kiuchi T et al. (2001) Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 72:449-454. doi: 10.1097/00007890-200108150-00016. PubMed: 11502975. (Pubitemid 32769631)
11. Sanchez-Fueyo A, Strom TB (2011) Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 140:51-64. doi:10.1053/j.gastro. 2010.10.059. PubMed: 21073873.
12. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP et al. (2012) Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 307:283-293. doi:10.1001/jama.2011.2014. PubMed: 22253395.
13. Gandhi CR (2011) Stellate Cells. In Molecular Pathology of Liver Diseases. In. SP Monga. Springer. pp. 53-80.
14. Thirunavukkarasu C, Uemura T, Wang LF, Watkins SC, Gandhi CR (2005) Normal rat hepatic stellate cells respond to endotoxin in LBPindependent manner to produce inhibitor (s) of DNA synthesis in hepatocytes. J Cell Physiol 204:654-665. doi:10.1002/jcp. 20366. PubMed: 15828022. (Pubitemid 40934662)
15. Gandhi CR, Uemura T, Kuddus RH (2000) Endotoxin causes upregulation of endothelin receptors in cultured hepatic stellate cells via nitric oxide-dependent and -independent mechanisms. Br J Pharmacol 131:319-327. doi:10.1038/sj.bjp. 0703577. PubMed: 10991926.
16. Uemura T, Gandhi CR (2001) Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-β- and nitric oxide-independent. Br J Pharmacol 133:1125-1133. doi:10.1038/sj.bjp. 0704151. PubMed: 11487524. (Pubitemid 32762424)
17. Thirunavukkarasu C, Watkins SC, Gandhi CR (2006) Mechanisms of endotoxin-induced nitric oxide, interleukin-6 and tumor necrosis factor-a production in activated rat hepatic stellate cells: role of p38MAPK. Hepatology 44:389-398. doi:10.1002/hep. 21254. PubMed: 16871588. (Pubitemid 44214878)
18. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med; 13:1324-1332. doi:10.1038/nm1663. PubMed: 17952090. (Pubitemid 350073596)
19. Dangi A, Sumpter TL, Kimura S, Stolz DB, Murase N et al. (2012) Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J Immunol 188:3667-3677. doi:10.4049/jimmunol.1102460. PubMed: 22427640.
20. Sumpter TL, Dangi A, Matta BM, Huang C, Stolz DB et al. (2012) Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO. J Immunol 189:3848-3858. doi:10.4049/jimmunol.1200819. PubMed: 22962681.
21. Holt AP, Haughton EL, Lalor PF, Filer A, Buckley CD et al. (2009) Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 136:705-714. doi:10.1053/j.gastro. 2008.10.020. PubMed: 19010327.
22. Von Boehmer H (2007) Oral tolerance: is it all retinoic acid? J Exp Med 204:1737-1739. doi:10.1084/jem.20071251. PubMed: 17620364. (Pubitemid 47236311)
23. Eksteen B, Mora JR, Haughton EL, Henderson NC, Lee-Turner L et al. (2009) Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells. Gastroenterology 137:320-329. doi:10.1053/j.gastro.2009.02.046. PubMed: 19233184.
24. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C et al. (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26:117-129. doi:10.1016/j.immuni.2006.11.011. PubMed: 17239632. (Pubitemid 46109346)
25. Yu MC, Chen CH, Liang X, Wang L, Gandhi CR et al. (2004) Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40:1312-1321. doi:10.1002/hep. 20488. PubMed: 15565659. (Pubitemid 39657005)
26. Schildberg FA, Wojtalla A, Siegmund SV, Endl E, Diehl L et al. (2011) Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology 54:262-272. doi:10.1016/S0168-8278 (11) 60650-8. PubMed: 21488077.
27. Chinnadurai R, Grakoui A (2010) B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells. Hepatology 52:2177-2185. doi:10.1002/hep. 23953. PubMed: 21064155.
28. Jiang G, Yang HR, Wang L, Wildey GM, Fung J et al. (2008) Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation 86:1492-1502. doi:10.1097/TP.0b013e31818bfd13. PubMed: 19077880.
29. Ichikawa S, Mucida D, Tyznik AJ, Kronenberg M, Cheroutre H (2011) Hepatic stellate cells function as regulatory bystanders. J Immunol 186:5549-5555. doi:10.4049/jimmunol.1003917. PubMed: 21460203.
30. Stewart R, Dangi A, Huang C, Murase N, Kimura S et al. (2013) A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury. J Hepatol (In the press).
31. Mencin A, Kluwe J, Schwabe RF (2009) Toll-like receptors as targets in chronic liver diseases. Gut 58:704-720. doi:10.1136/gut.2008.156307. PubMed: 19359436.
32. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C et al. (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37:1043-1055. doi:10.1053/jhep. 2003.50182. PubMed: 12717385. (Pubitemid 36538681)
33. Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D (2005) Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 289:G571-G578. doi:10.1152/ajpgi.00537.2004. PubMed: 15860640. (Pubitemid 41216395)
34. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H et al. (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196-200. doi:10.1038/ni758. PubMed: 11812998. (Pubitemid 34141451)
35. Wang CH, Eng HL, Lin KH, Chang CH, Hsieh CA et al. (2011) TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLOS ONE 6:e26235. doi:10.1371/journal.pone.0026235. PubMed: 22022576.
36. Watanabe N, Aizaki H, Matsuura T, Kojima S, Wakita T et al. (2011) Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules. Biochem Biophys Res Commun 407:135-140. doi:10.1016/j.bbrc.2011.02.125. PubMed: 21371436.
37. Tarantino G, Di Cristina A, Pipitone R, Almasio PL, Di Vita G et al. (2013) In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C. J Biol Regul Homeost Agents 2:233-339. PubMed: 23489702.
38. Perugorria MJ, Murphy LB, Fullard N, Chakraborty JB, Vyrla D et al. (2013) Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptorinduced TIMP-1 gene transcription in hepatic stellate cells in mice. Hepatology 57:1238-1249. doi:10.1002/hep. 26108. PubMed: 23080298.
39. Stafford MJ, Morrice NA, Peggie MW, Cohen P (2006) Interleukin-1 stimulated activation of the COT catalytic subunit through the phosphorylation of Thr290 and Ser62. FEBS Lett 580:4010-4014. doi: 10.1016/j.febslet.2006.06. 004. PubMed: 16806191. (Pubitemid 43946869)
40. Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN (2002) Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J 21:4831-4840. doi: 10.1093/emboj/cdf478. PubMed: 12234923.
41. Cismasiu VB, Duque J, Paskaleva E, Califano D, Ghanta S et al. (2009) BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes. Biochem J 417:457-466
42. Lopez-Pelaez M, Soria-Castro I, Bosca L, Fernandez M, Alemany S (2011) Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression. Eur J Immunol 41:1733-1741. doi:10.1002/eji.201041101. PubMed: 21469113.
43. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer Zum Buschenfelde KH et al. (1995) Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS). Challenge - J Hepatol 22:226-229.
44. Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M et al. (2009) Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458:1180-1184. doi:10.1038/nature07774. PubMed: 19407801.
45. Muta T, Yamazaki S, Eto A, Motoyama M, Takeshige K (2003) IkappaB-zeta, a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-kappaB. J Endotoxin Res 9:187-191. doi:10.1177/09680519030090030801. PubMed: 12831461. (Pubitemid 36722599)
46. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373-384. doi:10.1038/ni.1863. PubMed: 20404851.
47. Kong X, Feng D, Wang H, Hong F, Bertola A et al. (2012) Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 56:1150-1159.
48. Handy JA, Fu PP, Kumar P, Mells JE, Sharma S et al. (2011) Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J 440:385-395. doi: 10.1042/BJ20102148. PubMed: 21846328.
49. Fitzner B, Brock P, Nechutova H, Glass A, Karopka T et al. (2007) Inhibitory effects of interferon-gamma on activation of rat pancreatic stellate cells are mediated by STAT1 and involve down-regulation of CTGF expression. Cell Signal 19:782-790. doi:10.1016/j.cellsig. 2006.10.002. PubMed: 17116388.
50. Schaeffer V, Arbabi S, Garcia IA, Knoll ML, Cuschieri J et al. (2011) Role of the mTOR pathway in LPS-activated monocytes: influence of hypertonic saline. J Surg Res 171:769-776. doi:10.1016/j.jss. 2010.05.035. PubMed: 20828737.
51. Baker AK, Wang R, Mackman N, Luyendyk JP (2009) Rapamycin enhances LPS induction of tissue factor and tumor necrosis factoralpha expression in macrophages by reducing IL-10 expression. Mol Immunol 46:2249-2255. doi:10.1016/j.molimm.2009.04.011. PubMed: 19447494.
52. Fielhaber JA, Carroll SF, Dydensborg AB, Shourian M, Triantafillopoulos A et al. (2012) Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis. J Immunol 188:4535-4542. doi:10.4049/jimmunol.1003655. PubMed: 22450807.
53. Zhong LM, Zong Y, Sun L, Guo JZ, Zhang W et al. (2012) Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLOS ONE 7:e32195. doi:10.1371/journal.pone.0032195. PubMed: 22363816.
54. Wang SC, Ohata M, Schrum L, Rippe RA, Tsukamoto H (1998) Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 273:302-308. doi:10.1074/jbc.273.1.302. PubMed: 9417080. (Pubitemid 28042209)
55. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467-476. doi:10.1016/j.immuni. 2004.08.018. PubMed: 15485625. (Pubitemid 39370503)
56. Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y et al. (2012) Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143:765-776.
57. Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H et al. (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167:4137-4140. PubMed: 11591732. (Pubitemid 32954284)
58. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Evanoff HL et al. (2000) Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J Immunol 164:2738-2744. PubMed: 10679115. (Pubitemid 30115507)
59. Valatas V, Kolios G, Manousou P, Xidakis C, Notas G et al. (2004) Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotide. Regul Pept 120:215-225. doi:10.1016/j.regpep. 2004.03.009. PubMed: 15177940. (Pubitemid 38726210)
60. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485. doi:10.1038/nature09907. PubMed: 21478870.
61. Klune JR, Dhupar R, Kimura S, Ueki S, Cardinal J et al. (2012) Interferon regulatory factor-2 is protective against hepatic ischemiareperfusion injury. Am J Physiol Gastrointest Liver Physiol 303:G666-G673. doi:10.1152/ajpgi.00050. 2012. PubMed: 22744333.
62. Ueki S, Dhupar R, Cardinal J, Tsung A, Yoshida J et al. (2010) Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury. Hepatology 51:1692-1701. doi:10.1002/hep. 23501. PubMed: 20131404.
63. Dhupar R, Klune JR, Evankovich J, Cardinal J, Zhang M et al. (2011) Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemiareperfusion injury. Shock 35:293-301. doi:10.1097/SHK. 0b013e3181f6aab0. PubMed: 20856174.
64. Prakash A, Smith E, Lee CK, Levy DE (2005) Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem 280:18651-18657. doi:10.1074/jbc. M501289200. PubMed: 15767254. (Pubitemid 41379565)
65. Ning S, Pagano JS, Barber GN (2011) IRF7: activation, regulation, modification and function. Genes Immun 12:399-414. doi:10.1038/gene.2011.21. PubMed: 21490621.
66. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H et al. (2004) Interferonalpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5:1061-1068. doi: 10.1038/ni1118. PubMed: 15361868. (Pubitemid 41057726)
67. Maiwald T, Schneider A, Busch H, Sahle S, Gretz N et al. (2010) Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling. FEBS J 277:4741-4754. doi:10.1111/j. 1742-4658.2010.07880.x. PubMed: 20964804.
68. Yamada H, Odonnell MA, Matsumoto T, Luo Y (2005) Interferongamma up-regulates toll-like receptor 4 and cooperates with lipopolysaccharide to produce macrophage-derived chemokine and interferon-gamma inducible protein-10 in human bladder cancer cell line RT4. J Urol 174:1119-1123. doi:10.1097/01.ju. 0000168619.25341.96. PubMed: 16094077. (Pubitemid 41140698)
69. Leifeld L, Dumoulin FL, Purr I, Janberg K, Trautwein C et al. (2003) Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol 199:335-344. doi:10.1002/path.1298. PubMed: 12579535. (Pubitemid 36266856)
70. Schwabe RF, Bataller R, Brenner DA (2003) Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 285:G949-G958. PubMed: 12829440. (Pubitemid 37310074)
71. Katsounas A, Trippler M, Wang B, Polis M, Lempicki RA et al. (2012) CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling. J Viral Hepat 19:128-137. doi:10.1111/j.1365-2893.2011.01503.x. PubMed: 22239502.
72. Seki E, De Minicis S, Inokuchi S, Taura K, Miyai K et al. (2009) CCR2 promotes hepatic fibrosis in mice. Hepatology 50:185-197. doi: 10.1002/hep. 22952. PubMed: 19441102.
73. Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL (2002) Role of CCR2 in macrophage migration into the liver during acetaminophen induced hepatotoxicity in the mouse. Hepatology 35:1093-1103. doi:10.1053/jhep. 2002.33162. PubMed: 11981759. (Pubitemid 34454006)
74. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Matsukawa A, Gosling J et al. (2000) Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am J Pathol 156:1245-1252. doi:10.1016/S0002-9440 (10) 64995-4. PubMed: 10751350. (Pubitemid 30660003)
75. Dong H, Toyoda N, Yoneyama H, Kurachi M, Kasahara T et al. (2002) Gene expression profile analysis of the mouse liver during bacteriainduced fulminant hepatitis by a cDNA microarray system. Biochem Biophys Res Commun 298:675-686. doi:10.1016/S0006-291X (02) 02528-7. PubMed: 12419307. (Pubitemid 35356793)
76. Xu HB, Gong YP, Jiang ZG, Liu RZ, Xiong SD (2005) The role of CXCL16 in immunological liver injury induced by BCG and LPS in mice. Zhonghua Gan Zang Bing Za Zhi 13:282-285. PubMed: 15850518.
77. Stefanovic L, Brenner DA, Stefanovic B (2005) Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp Biol Med (Maywood) 230:573-586. PubMed: 16118408. (Pubitemid 41233157)
78. Tuyama AC, Hong F, Saiman Y, Wang C, Ozkok D et al. (2010) Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 52:612-622. doi:10.1002/hep. 23679. PubMed: 20683959.
79. Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD et al. (2000) Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13:233-242. doi:10.1016/S1074-7613 (00) 00023-6. PubMed: 10981966.
80. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R et al. (2000) Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290:1768-1771. doi:10.1126/science. 290.5497.1768. PubMed: 11099416. (Pubitemid 32004808)
81. Gorczynski RM, Chen Z, Clark DA, Kai Y, Lee L et al. (2004) Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the feto-maternal interface. Am J Reprod Immunol 52:147-163. doi:10.1111/j.1600-0897.2004.00192.x. PubMed: 15274657. (Pubitemid 39149320)
82. Rao HY, Wei L, Wang JH, Fei R, Jiang D (2010) Inhibitory effect of human interferon-beta-1a on activated rat and human hepatic stellate cells. J Gastroenterol Hepatol 25:1777-1184. doi:10.1111/j. 1440-1746.2010.06264.x. PubMed: 21039841.
83. Park I, Han C, Jin S, Lee B, Choi H et al. (2011) Myosin regulatory light chains are required to maintain the stability of myosin II and cellular integrity. Biochem J 434:171-180. doi:10.1042/BJ20101473. PubMed: 21126233.
84. Uchinami H, Seki E, Brenner DA, D'Armiento J (2006) Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 44:420-429. doi:10.1002/hep. 21268. PubMed: 16871591. (Pubitemid 44214881)
85. Han YP, Yan C, Zhou L, Qin L, Tsukamoto H (2007) A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix. J Biol Chem 282:12928-12939. doi:10.1074/jbc. M700554200. PubMed: 17322299. (Pubitemid 47100583)